Cargando…
Acquired epidermodysplasia verruciformis in setting of tumor necrosis factor-α inhibitor therapy
Autores principales: | Schultz, Brittney, Nguyen, Cuong V., Jacobson-Dunlop, Erick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141641/ https://www.ncbi.nlm.nih.gov/pubmed/30246133 http://dx.doi.org/10.1016/j.jdcr.2018.05.021 |
Ejemplares similares
-
Acquired epidermodysplasia verruciformis secondary to methotrexate
por: AlFada, Mohammed A., et al.
Publicado: (2022) -
Acquired epidermodysplasia verruciformis in renal‐transplant recipients
por: Gara, Soumaya, et al.
Publicado: (2020) -
Acquired Epidermodysplasia Verruciformis During Highly Active Antiretroviral Therapy
por: Sil, Abheek, et al.
Publicado: (2022) -
Epidermodysplasia Verruciformis and Susceptibility to HPV
por: Patel, Tejas, et al.
Publicado: (2010) -
Acrokeratosis Verruciformis of Hopf Clinically Mimicking Epidermodysplasia Verruciformis
por: Diwan, Nilofar G, et al.
Publicado: (2016)